Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryam Dastmalchi

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|November 10, 2025
Relapse Rate After Glucocorticoid-free Remission in patients with Idiopathic Inflammatory Myopathies and Validation of the International Myositis Assessment and Clinical Studies Group (IMACS) Criteria for Complete Clinical Response and WorseningHideaki Tsuji, Fabricio Espinosa-Ortega, Irene Peralta Garcia, et al.
Arthritis and Rheumatism|October 2, 2007
Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositisMaryam Dastmalchi, Helene Alexanderson, Ingela Loell, et al.
Clinical and Experimental Rheumatology|December 16, 2016
Use of biologic agents in idiopathic inflammatory myopathies in Sweden: a descriptive study of real life treatmentJohn Svensson, Marie Holmqvist, Anna Tjärnlund, et al.
Annals of the Rheumatic Diseases|February 6, 2007
Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathiesSevim Barbasso Helmers, Maryam Dastmalchi, Helene Alexanderson, et al.
The Journal of Rheumatology|February 9, 2018
Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective StudyHelene Alexanderson, Malin Regardt, Christina Ottosson, et al.
The Journal of Rheumatology|May 3, 2014
Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis -- a randomized controlled single-blinded study with a 2-year followupHelene Alexanderson, Li Alemo Munters, Maryam Dastmalchi, et al.
Lakartidningen|September 9, 2022
[Myositis-related interstitial lung disease - a systemic autoimmune desease often overlooked]Karin Lodin, Antonella Notarnicola, Maryam Dastmalchi, et al.
Arthritis Research & Therapy|May 4, 2018
Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositisJoan Raouf, Helena Idborg, Petter Englund, et al.
Journal of Autoimmunity|December 26, 2016
The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositisXin Lu, Quan Tang, Monica Lindh, et al.
Medicine|June 27, 2012
Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literatureAne Labirua-Iturburu, Albert Selva-O'Callaghan, Melinda Vincze, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Arthritis & Rheumatology (Hoboken, N.J.)|November 10, 2025
Relapse Rate After Glucocorticoid-free Remission in patients with Idiopathic Inflammatory Myopathies and Validation of the International Myositis Assessment and Clinical Studies Group (IMACS) Criteria for Complete Clinical Response and WorseningHideaki Tsuji, Fabricio Espinosa-Ortega, Irene Peralta Garcia, et al.
Arthritis and Rheumatism|October 2, 2007
Effect of physical training on the proportion of slow-twitch type I muscle fibers, a novel nonimmune-mediated mechanism for muscle impairment in polymyositis or dermatomyositisMaryam Dastmalchi, Helene Alexanderson, Ingela Loell, et al.
Clinical and Experimental Rheumatology|December 16, 2016
Use of biologic agents in idiopathic inflammatory myopathies in Sweden: a descriptive study of real life treatmentJohn Svensson, Marie Holmqvist, Anna Tjärnlund, et al.
Annals of the Rheumatic Diseases|February 6, 2007
Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathiesSevim Barbasso Helmers, Maryam Dastmalchi, Helene Alexanderson, et al.
The Journal of Rheumatology|February 9, 2018
Muscle Strength and Muscle Endurance During the First Year of Treatment of Polymyositis and Dermatomyositis: A Prospective StudyHelene Alexanderson, Malin Regardt, Christina Ottosson, et al.
The Journal of Rheumatology|May 3, 2014
Resistive home exercise in patients with recent-onset polymyositis and dermatomyositis -- a randomized controlled single-blinded study with a 2-year followupHelene Alexanderson, Li Alemo Munters, Maryam Dastmalchi, et al.
Lakartidningen|September 9, 2022
[Myositis-related interstitial lung disease - a systemic autoimmune desease often overlooked]Karin Lodin, Antonella Notarnicola, Maryam Dastmalchi, et al.
Arthritis Research & Therapy|May 4, 2018
Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositisJoan Raouf, Helena Idborg, Petter Englund, et al.
Journal of Autoimmunity|December 26, 2016
The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositisXin Lu, Quan Tang, Monica Lindh, et al.
Medicine|June 27, 2012
Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literatureAne Labirua-Iturburu, Albert Selva-O'Callaghan, Melinda Vincze, et al.
Pageof 5